Investigating the role of ANP32A in the replication of Avian influenza Virus

Lead Research Organisation: Imperial College London
Department Name: Infectious Disease

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

Influenza viruses infect domestic animals including poultry and pigs, causing loss of income, social and economic disruption. Avian influenza remains one of the major threats to food security. Adaptation of avian influenza in animal hosts leads to viruses that are transmitted in humans and carries the risk of driving emergent influenza pandemics. We have investigated a family of host proteins, ANP32, that are co-opted by influenza virus to support its replication. The difference between ANP32A in chickens and mammalian hosts accounts for one of the host range barriers that protect pigs and humans from zoonotic infections by avian influenza viruses. Avian influenza virus RNA-dependent RNA polymerase is unable to utilise the mammalian ANP32A protein unless it adapts by mutation of the viral PB2 protein. We will first identify the specific regions of ANP32A needed for viral protein interactions. We will use new genome editing tools that we have developed to modify chicken cells, to identify functional regions/amino acids by testing the effectiveness of specific mutations to abrogate these host:viral interactions. We will determine any global changes in the RNA transcriptome of the edited cells containing modified ANP32A protein and characterise any other effects of these modifications, unrelated to avian influenza infection. We will investigate the function of ANP32A in genome edited animals.

Planned Impact

Agricultural losses to avian influenza have major impacts through recurring outbreaks in tropical environments mostly in developing countries. Small holder farmers and subsistence farmers lose valuable resources (in terms of livestock) during these outbreaks. The Gates Foundation has invested in promoting scavenger chicken to improve the livelihoods of subsistence farmers, with a strong focus on women who are usually the primary owners of rural chicken. The Gates Foundation is also investing in research at The Roslin Institute (through the Centre for Tropical Livestock Genetics and Health) to develop disease resistance using genetic approaches in poultry, to alleviate the need for vaccination programmes.
Agricultural losses by high pathogenic avian influenza are also severe in developed countries. The 'bird flu' outbreak in the USA in 2015 led to the culling of 48 million layer chickens and turkeys. The economic loss from this outbreak is estimated to be $1.3 billion. Most of these losses were due to the loss of the export market as live poultry products can no longer be exported from affected countries during HPAI incidents.
The major advances in understanding the interaction between specific host genes and influenza virus replication that we propose to investigate here will inform genetic strategies for control of avian influenza in production chickens.
Another primary beneficiary of our research will be the research community, especially those researchers working in avian biology or poultry production. We will exemplify the development and use of new genetic tools for investigating gene function and viral resistance in poultry. This will enable researchers to replace some animal model challenges with cell-based challenges. Poultry researchers will also benefit by the example of creating chicken genetic models that can be used to investigate pathways of infections and resistance.
 
Description Work funded by this award has identified specific mutations which render the chicken host factor ANP32A unable to support replication of flu. Mutations at positions 129 and 130 of the chicken ANP32A gene have been introduced into chicken germ cells to demonstrate loss of support of flu virus in these cells. However, some replication can still occur so we are now looking to characterise escape mutants and to use recent structural data to identify specific mutations at the N-terminus of ANP32A in order to abrogate its recruitment of a second polymerase. Work is also ongoing into the potential role of ANP32E in support of influenza polymerase since it might be that editing of this second chicken gene will be require to completely abrogate influenza infection.
We have now identified several different escape mutations in the viruses isolated from gene edited chickens that enable the virus to continue to replicate using the modified host factor. We can see that these affect the dimerization potential of the polymerase enzyme and this is revealing key regulatory mechanisms. we can also see the mutations may make it more likely that the virus can replicate in mammalian cells using mammalian ANP32 proteins that are shorted than avian ANP32A. This is worrisome and make the impact of our finding very significant. We are preparing a high profile publication to share these findings widely.
Exploitation Route These findings can be applied directly to the production of gene edited chickens which are resistant to flu. This has the potential to reduce bird culling in the poultry industry in response to flu outbreaks and potentially to reduce the incidence of human flu pandemics by removing poultry as a source of novel reassortant viruses. However importantly our findings show that simple modifications may also lead to virus mutations and the design of gene edits must be carefully assessed.
Sectors Agriculture, Food and Drink

 
Description A patent application is being considered, based on our findings, to generate influenza resistant chickens. Advice has been given to policy makers around the generation and use of gene edited animals for farming.
First Year Of Impact 2022
Sector Agriculture, Food and Drink
Impact Types Policy & public services

 
Description Nervtag advisor
Geographic Reach National 
Policy Influence Type Implementation circular/rapid advice/letter to e.g. Ministry of Health
Impact Nervtag Advisor
 
Description Roslin collaboration 
Organisation University of Edinburgh
Department The Roslin Institute
Country United Kingdom 
Sector Academic/University 
PI Contribution We have collaborated with this group and are publishing a paper together, we have shared pertinent unpublished data together as well as laboratory reagents
Collaborator Contribution We have collaborated with this group and are publishing a paper together, we have shared pertinent unpublished data together as well as laboratory reagents
Impact A paper is currently in revisions and should be published soon in Journal of Virology.
Start Year 2019
 
Description Astbury conversation "Inside the cell with influenza virus." 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact Talk
Year(s) Of Engagement Activity 2022
URL https://astburyconversation.leeds.ac.uk/ehome/index.php?eventid=200183132&
 
Description Australasian Virology Society's 21st Anniversary Meeting (AVS11), held in Australia, 5-8 December 2022. 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Virology in Australia to share and encourage collaborations and exchange of knowledge
Year(s) Of Engagement Activity 2022
URL https://www.avs.org.au/
 
Description Cardiff University Infection & Immunity meeting 2022 'Saving the world from the next pandemic' 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact Infection and Immunity annual meeting 2022

Cardiff City Stadium, Leckwith Road, Cardiff, CF11 8AZ, United Kingdom
Year(s) Of Engagement Activity 2022
URL https://www.cardiff.ac.uk/systems-immunity
 
Description NSV portugal organiser XVIII International Conference on Negative Strand Viruses 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact co-organiser
Year(s) Of Engagement Activity 2022
 
Description isirv - OPTIONS for the Control of Influenza XI Belfast Keynote speaker talk title Influenza research in the post COVID era 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact To share knowledge and further study Influenza
Year(s) Of Engagement Activity 2022
URL https://www.isirv.org/site/